The HemOnc Pulse
Is MRD Negativity the New Benchmark in ALL Treatment Strategies?
Elias Jabbour, MD, an Executive Editor of Blood Cancers Today and a Professor of Leukemia at the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss the functi